Section Arrow
Quote
EXAS.NASDAQ
- Exact Sciences Corp
Quotes are at least 15-min delayed:2024/05/10 02:11 EDT
Last
 54.15
-5.33 (-8.96%)
Day High 
55.38 
Prev. Close
59.48 
1-M High
74.44 
Volume 
10.69M 
Bid
54.12
Ask
54.97
Day Low
52.25 
Open
54.5 
1-M Low
57.5529 
Market Cap 
10.94B 
Currency USD 
P/E -- 
%Yield 0 
10-SMA 60.26 
20-SMA 62.65 
50-SMA 63.39 
52-W High 100.77 
52-W Low 52.25 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.13/0.08
Enterprise Value
13.41B
Balance Sheet
Book Value Per Share
17.11
Cash Flow
Cash Flow Yield
0.01
Income Statement
Total Revenue
2.50B
Operating Revenue Per Share
13.09
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
EXASExact Sciences Corp54.15-5.33-8.96%-- 
SHCSotera Health Company11.34+0.125+1.11%62.31PE
LABStandard BioTools2.42+0.18+8.04%-- 
NTRANatera95.61-0.05-0.05%-- 
GHGuardant Health19.44+0.8+4.29%-- 
Quotes are at least 15-min delayed：2024/05/10 02:11 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy forbreast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening, too.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.